TNF and colitis: Connectivity Map analysis identified MS.275 as the top therapeutic enhancer, with experimental validation in DSS-induced colitis confirming synergistic anti-inflammatory effects with TNF-α inhibitors, improving disease activity indices and restoring signature gene expression patterns.